Patients’ characteristic
| Demographic characteristics | Midazolam+placebo (n=29) | Midazolam+ketamine (n=31) | Mean difference (95% CI) | p Value |
|---|---|---|---|---|
| Age (years)±SD | 5.26±2.26 | 4.76±2.29 | 0.5 (−0.85 to 1.46) | 0.46 |
| Weight (kg)±SD | 18.12±5.92 | 17.27±4.65 | 0.85 (−1.9 to 3.6) | 0.53 |
| Male (n=32)±SD (%) | 15 (51) | 17 (54) | 1 | |
| Facial laceration (%) | 25 (86) | 23 (74) | 0.33 | |
| Midazolam dose (mg)±SD | 8.77±2.6 | 8.63±2.32 | 0.14 (−1.14 to 1.14) | 0.83 |
| Ketamine/placebo dose (mg)±SD | 93.28±33.36 | 84.52±23.42 | 8.76 (−6.06 to 23.58) | |
| VAS before procedure (CM)±SD | 0.33±0.91 | 0.41±0.98 | 0.08 (−0.47 to 0.63) | 0.77 |
VAS, visual analogue scale.